ScRNA-seq revealed the kinetic of nasopharyngeal immune responses in asymptomatic COVID-19 carriers

Qi，Furong1; Xu，Gang1; Liao，Xuejiao1; Wang，Fuxiang2; Yuan，Jing2; Wang，Haiyan1; Wang，Xin1; Liu，Lei1,3; Zhang，Shuye4; Zhang，Zheng1,3,5,6

2021-12-01

English

Bill and Melinda Gates Institute for Population and Reproductive Health[2020-PT310-009];Science, Technology and Innovation Commission of Shenzhen Municipality[2020A1111350032];Natural Science Foundation of Guangdong Province[2020B1111340027];Natural Science Foundation of Guangdong Province[2020B1111340039];China National Funds for Distinguished Young Scientists[82025022];

10.1038/s41421-021-00294-x

Cell Discovery

7

1

2056-5968

SCI

First ; Corresponding

2-s2.0-85111593932

Scopus

WOS:000679927000001

2056-5968

1.Institute for Hepatology,National Clinical Research Center for Infectious Disease,Shenzhen Third People’s Hospital; The Second Affiliated Hospital,School of Medicine,Southern University of Science and Technology,Shenzhen,China
2.Department for Infectious Diseases,Shenzhen Third People’s Hospital,Shenzhen,China
3.Shenzhen Research Center for Communicable Disease Diagnosis and Treatment of Chinese Academy of Medical Science,Shenzhen,China
4.Shanghai Public Health Clinical Center,Fudan University,Shanghai,China
5.Shenzhen Bay Laboratory,Shenzhen,China
6.Guangdong Key Laboratory for Anti-infection Drug Quality Evaluation,Shenzhen,China

Qi，Furong,Xu，Gang,Liao，Xuejiao,et al. ScRNA-seq revealed the kinetic of nasopharyngeal immune responses in asymptomatic COVID-19 carriers. 2021-12-01.